The FDA granted clearance to SPR Therapeutics’ single- and dual-lead peripheral nerve stimulation devices as minimally invasive, non-opioid alternatives, implanted for up to 60 days for relieving acute and chronic pain, including postoperative and post-traumatic pain.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,